Placenta Accreta Spectrum and Postpartum Hemorrhage.
Journal
Clinical obstetrics and gynecology
ISSN: 1532-5520
Titre abrégé: Clin Obstet Gynecol
Pays: United States
ID NLM: 0070014
Informations de publication
Date de publication:
01 06 2023
01 06 2023
Historique:
medline:
29
5
2023
pubmed:
2
5
2023
entrez:
2
5
2023
Statut:
ppublish
Résumé
Placenta accreta spectrum is a group of disorders involving abnormal trophoblastic invasion to the deep layers of endometrium and myometrium. Placenta accrete spectrum is one of the major causes of severe maternal morbidity, with increasing incidence in the past decade mainly secondary to an increase in cesarean deliveries. Severity varies depending on the depth of invasion, with the most severe form, known as percreta, invading uterine serosa or surrounding pelvic organs. Diagnosis is usually achieved by ultrasound, and MRI is sometimes used to assess invasion. Management usually involves a hysterectomy at the time of delivery. Other strategies include delayed hysterectomy or expectant management.
Identifiants
pubmed: 37130375
doi: 10.1097/GRF.0000000000000783
pii: 00003081-202306000-00018
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
399-407Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Gynecologists ACoOa, Medicine SfM-F. Obstetric Care Consensus No. 7: Placenta Accreta Spectrum. Obstet Gynecol. 2018;132:e259–e275
Usta IM, Hobeika EM, Musa AA, et al. Placenta previa-accreta: risk factors and complications. Am J Obstet Gynecol. 2005;193(3Pt2):1045–1049 ; (In eng).
Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005;192:1458–1461 ; (In eng).
Mogos MF, Salemi JL, Ashley M, et al. Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-associated costs, 1998-2011. J Matern Fetal Neonatal Med. 2016;29:1077–1082 ; (In eng).
Marshall NE, Fu R, Guise JM. Impact of multiple cesarean deliveries on maternal morbidity: a systematic review. Am J Obstet Gynecol. 2011;205:262.e1–8 ; (In eng).
Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018;218:75–87 ; (In eng).
Silver RM, Landon MB, Rouse DJ, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006;107:1226–1232 ; (In eng).
Bujold E. The optimal uterine closure technique during cesarean. N Am J Med Sci. 2012;4:362–363 ; (In eng).
Sumigama S, Sugiyama C, Kotani T, et al. Uterine sutures at prior caesarean section and placenta accreta in subsequent pregnancy: a case-control study. BJOG. 2014;121:866–874; discussion 875.; (In eng).
Twickler DM, Lucas MJ, Balis AB, et al. Color flow mapping for myometrial invasion in women with a prior cesarean delivery. J Matern Fetal Med. 2000;9:330–335 ; (In eng).
Jauniaux E, Chantraine F, Silver RM, et al. Panel FPADaMEC. FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology. Int J Gynaecol Obstet. 2018;140:265–273 ; (In eng).
Kohn JR, Shamshirsaz AA, Popek E, et al. Pregnancy after endometrial ablation: a systematic review. BJOG. 2018;125:43–53 ; (In eng).
Salmanian B, Fox KA, Arian SE, et al. In vitro fertilization as an independent risk factor for placenta accreta spectrum. Am J Obstet Gynecol. 2020;223:568.e1–568.e5 ; (In eng).
Jitsumori M, Matsuzaki S, Endo M, et al. Obstetric outcomes of pregnancy after uterine artery embolization. Int J Womens Health. 2020;12:151–158 ; (In eng).
McNally L, Zhou Y, Robinson JF, et al. Up-regulated cytotrophoblast DOCK4 contributes to over-invasion in placenta accreta spectrum. Proc Natl Acad Sci U S A. 2020;117:15852–15861 ; (In eng).
Chen B, Wang D, Bian Y, et al. Systematic identification of hub genes in placenta accreta spectrum based on integrated transcriptomic and proteomic analysis. Front Genet. 2020;11:551495 ; (In eng).
Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, et al. Panel FPADaMEC. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146:20–24 ; (In eng).
Aalipour S, Salmanian B, Fox KA, et al. Placenta Accreta Spectrum: Correlation between FIGO Clinical Classification and Histopathologic Findings. Am J Perinatol. 2021.; (In eng).
Jauniaux E, Bhide A, Kennedy A, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. Int J Gynaecol Obstet. 2018;140:274–280 ; (In eng).
Bowman ZS, Eller AG, Kennedy AM, et al. Accuracy of ultrasound for the prediction of placenta accreta. Am J Obstet Gynecol. 2014;211:177.e1–7 ; (In eng).
Thurn L, Lindqvist PG, Jakobsson M, et al. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG. 2016;123:1348–1355 ; (In eng).
Comstock CH. Re: Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. F D’Antonio, C Iacovella and A Bhide Ultrasound Obstet Gynecol 2013; 42: 509-517 Ultrasound Obstet Gynecol. 2013;42:498 ; (In eng).
Bowman ZS, Eller AG, Kennedy AM, et al. Interobserver variability of sonography for prediction of placenta accreta. J Ultrasound Med. 2014;33:2153–2158 ; (In eng).
Alfirevic Z, Tang AW, Collins SL, et al. Group A-hIAE. Pro forma for ultrasound reporting in suspected abnormally invasive placenta (AIP): an international consensus. Ultrasound Obstet Gynecol. 2016;47:276–278 ; (In eng).
Shih JC, Kang J, Tsai SJ, et al. The “rail sign”: an ultrasound finding in placenta accreta spectrum indicating deep villous invasion and adverse outcomes. Am J Obstet Gynecol. 2021;225:292.e1–292.e17 ; (In eng).
Abdel Moniem AM, Ibrahim A, Akl SA, et al. Accuracy of three-dimensional multislice view Doppler in diagnosis of morbid adherent placenta. J Turk Ger Gynecol Assoc. 2015;16:126–136 ; (In eng).
Shih JC, Palacios Jaraquemada JM, Su YN, et al. Role of three-dimensional power Doppler in the antenatal diagnosis of placenta accreta: comparison with gray-scale and color Doppler techniques. Ultrasound Obstet Gynecol. 2009;33:193–203 ; (In eng).
Abinader RR, Macdisi N, El Moudden I, et al. First-trimester ultrasound diagnostic features of placenta accreta spectrum in low-implantation pregnancy. Ultrasound Obstet Gynecol. 2022;59:457–464 ; (In eng).
Doulaveris G, Ryken K, Papathomas D, et al. Early prediction of placenta accreta spectrum in women with prior cesarean delivery using transvaginal ultrasound at 11 to 14 weeks. Am J Obstet Gynecol MFM. 2020;2:100183 ; (In eng).
Varghese B, Singh N, George RA, et al. Magnetic resonance imaging of placenta accreta. Indian J Radiol Imaging. 2013;23:379–385 ; (In eng).
Einerson BD, Rodriguez CE, Silver RM, et al. Accuracy and Interobserver Reliability of Magnetic Resonance Imaging for Placenta Accreta Spectrum Disorders. Am J Perinatol. 2021;38:960–967 ; (In eng).
Einerson BD, Rodriguez CE, Kennedy AM, et al. Magnetic resonance imaging is often misleading when used as an adjunct to ultrasound in the management of placenta accreta spectrum disorders. Am J Obstet Gynecol. 2018;218:618.e1–618.e7 ; (In eng).
Gyamfi-Bannerman C. pubs@smfm.org SfM-FMSEa. Society for Maternal-Fetal Medicine (SMFM) Consult Series #44: Management of bleeding in the late preterm period. Am J Obstet Gynecol. 2018;218:B2–B8 ; (In eng).
Shamshirsaz AA, Fox KA, Salmanian B, et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol. 2015;212:218.e1–9 ; (In eng).
Silver RM, Barbour KD. Placenta accreta spectrum: accreta, increta, and percreta. Obstet Gynecol Clin North Am. 2015;42:381–402 ; (In eng).
Belfort MA, Shamshiraz AA, Fox K. Minimizing blood loss at cesarean-hysterectomy for placenta previa percreta. Am J Obstet Gynecol. 2017;216:78.e1–78.e2 ; (In eng).
Morlando M, Collins S. Placenta accreta spectrum disorders: challenges, risks, and management strategies. Int J Womens Health. 2020;12:1033–1045 ; (In eng).
Tam Tam KB, Dozier J, Martin JN. Approaches to reduce urinary tract injury during management of placenta accreta, increta, and percreta: a systematic review. J Matern Fetal Neonatal Med. 2012;25:329–334 ; (In eng).
Crocetto F, Esposito R, Saccone G, et al. Use of routine ureteral stents in cesarean hysterectomy for placenta accreta. J Matern Fetal Neonatal Med. 2021;34:386–389 ; (In eng).
Al-Khan A, Guirguis G, Zamudio S, et al. Preoperative cystoscopy could determine the severity of placenta accreta spectrum disorders: An observational study. J Obstet Gynaecol Res. 2019;45:126–132 ; (In eng).
Chen M, Liu X, You Y, et al. Internal Iliac artery balloon occlusion for placenta previa and suspected placenta accreta: a randomized controlled trial. Obstet Gynecol. 2020;135:1112–1119 ; (In eng).
Manzano-Nunez R, Escobar-Vidarte MF, Naranjo MP, et al. Expanding the field of acute care surgery: a systematic review of the use of resuscitative endovascular balloon occlusion of the aorta (REBOA) in cases of morbidly adherent placenta. Eur J Trauma Emerg Surg. 2018;44:519–526 ; (In eng).
Tsurukiri J, Akamine I, Sato T, et al. Resuscitative endovascular balloon occlusion of the aorta for uncontrolled haemorrahgic shock as an adjunct to haemostatic procedures in the acute care setting. Scand J Trauma Resusc Emerg Med. 2016;24:13 ; (In eng).
Sentilhes L, Ambroselli C, Kayem G, et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010;115:526–534 ; (In eng).
Marcellin L, Delorme P, Bonnet MP, et al. Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta. Am J Obstet Gynecol. 2018;219:193.e1–193.e9 ; (In eng).
Matsuzaki S, Yoshino K, Endo M, et al. Conservative management of placenta percreta. Int J Gynaecol Obstet. 2018;140:299–306 ; (In eng).
Sentilhes L, Kayem G, Ambroselli C, et al. Fertility and pregnancy outcomes following conservative treatment for placenta accreta. Hum Reprod. 2010;25:2803–2810 ; (In eng).
Zuckerwise LC, Craig AM, Newton JM, et al. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum. Am J Obstet Gynecol. 2020;222:179.e1–179.e9 ; (In eng).
Ramoni A, Strobl EM, Tiechl J, et al. Conservative management of abnormally invasive placenta: four case reports. Acta Obstet Gynecol Scand. 2013;92:468–471 ; (In eng).
Fox KA, Shamshirsaz AA, Carusi D, et al. Conservative management of morbidly adherent placenta: expert review. Am J Obstet Gynecol. 2015;213:755–760 ; (In eng).
Gatta LA, Lee PS, Gilner JB, et al. Placental uterine artery embolization followed by delayed hysterectomy for placenta percreta: a case series. Gynecol Oncol Rep. 2021;37:100833 ; (In eng).
Rupley DM, Tergas AI, Palmerola KL, et al. Robotically assisted delayed total laparoscopic hysterectomy for placenta percreta. Gynecol Oncol Rep. 2016;17:53–55 ; (In eng).